Roche

Startups

Seattle biotech startup born out of a Roche buyout lands $93M to advance therapies

[ad_1] Seattle-based Bonum Therapeutics designs therapies that can be administered systemically for targeted activation in the body. (Good Therapeutics Graphic)…

Read More »
Startups

Roche to acquire Good Therapeutics’ lead drug program for $250M, plus milestone payments

[ad_1] Seattle-based Good Therapeutics designs therapies that can be administered systemically for targeted activation in the body. (Good Therapeutics Graphic)…

Read More »
Back to top button
Close